Navigation Links
Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets
Date:6/17/2011

TITUSVILLE, N.J., June 17, 2011 /PRNewswire/ -- Ortho-McNeil-Janssen Pharmaceuticals, Inc. is initiating a voluntary recall of one lot of RISPERDAL® (risperidone) 3mg Tablets, marketed by Janssen Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. and one lot of risperidone 2mg Tablets, marketed by Patriot Pharmaceuticals, LLC, a wholly owned subsidiary of Ortho-McNeil-Janssen Pharmaceuticals, Inc.  The recalls stem from two consumer reports of an uncharacteristic odor thought to be caused by trace amounts of TBA (2,4,6 tribromoanisole).TBA is a byproduct of a chemical preservative sometimes applied to wood often used in the construction of pallets on which materials are transported and stored.  In January 2010, the company instituted a number of actions to reduce the potential of TBA contamination, including requiring suppliers to certify that they do not use pallets made from chemically-treated wood.

While not considered to be toxic, TBA can generate an offensive odor and a very small number of patients have reported temporary gastrointestinal symptoms when taking other products with this odor.  As it relates to RISPERDAL® and risperidone, there have been no reported serious adverse events caused by the presence of TBA.

The RISPERDAL® lot – which includes approximately 16,000 bottles – was shipped between 8/27/2010 and 2/15/2011.  The company believes there are approximately 1,600 bottles of RISPERDAL® from this lot remaining in the marketplace.  The risperidone lot – which includes approximately 24,000 bottles – was shipped between 11/10/2010 and 1/01/2011.  The company believes there are fewer than 1,200 bottles of risperidone from this lot remaining in the marketplace.  Package DescriptionNDC CodeLot NumberExpiryRISPERDAL® (risperidone)
Tablets 3mg Bottles of 60 Tablets

50458-330-06

0GG904

May 2012Risperidone Tablets
2mg Bottles o
'/>"/>

SOURCE Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Announces Oncology Research Collaboration Agreement with the Koch Institute for Integrative Cancer Research at MIT
2. The Pittsburgh Life Sciences Greenhouse Congratulates Diamyd Medical on Its Agreement with Ortho-McNeil-Janssen Pharmaceuticals to Develop Diabetes Therapy
3. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Resolves Investigation of Past TOPAMAX(R) Marketing and Promotional Activities
4. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Agrees to $75 Million Settlement for Topamax(R) False Claims Lawsuit
5. AUDIO from Medialink and Ortho-McNeil-Janssen Pharmaceuticals Inc.: Getting Ready for Cold and Flu Season
6. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
7. Omthera Pharmaceuticals, Inc. to Present at the 2011 Wells Fargo Securities Healthcare Conference
8. Pacira Pharmaceuticals, Inc. Announces FDA Extension of EXPAREL™ PDUFA Target Date by Three Months
9. Ampio Pharmaceuticals, Inc. Appoints New Independent Director
10. Aeolus Pharmaceuticals, Inc. Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
11. Pacira Pharmaceuticals, Inc. Appoints Two Life Sciences Industry Veterans to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 2015  Omeros Corporation (NASDAQ: OMER ) today ... Par Pharmaceutical, Inc. and its subsidiary, Par Sterile Products, ... the District of New Jersey ... of Delaware . The lawsuits were ... three Omeros patents, U.S. Patent Nos. 8,173,707, 8,586,633 and ...
(Date:9/3/2015)... Sep. 03, 2015 ... announced the addition of the "Investigation ... report to their offering. Non-steroidal ... chemical structure from steroids which have a ... provide analgestic and antipyretic effects with fewer ...
(Date:9/3/2015)... DUBLIN , Sep. 03, 2015 ... announced the addition of the "Investigation Report on ... Oxiracetam, a derivative of pyrrolidone, was first ... drug whose oral preparation and injection entered the Italian ... develops fast after entering China , ...
Breaking Medicine Technology:Omeros Files Infringement Suits Against Par 2Omeros Files Infringement Suits Against Par 3Omeros Files Infringement Suits Against Par 4China Flurbiprofen Market Investigation Report 2010-2019 2Investigation Report on China's Oxiracetam Market, 2010-2019 2
... 2011 Northwest Biotherapeutics (OTC.BB: NWBO) today announced that ... exceeding its projections for the doubling of such sites ... new patients into the Company,s ongoing 240-patient randomized, double ... for Glioblastoma multiforme (GBM), the most lethal form of ...
... A study titled "Abiraterone and Increased Survival ... 26 issue of NEJM, found that ... received prior chemotherapy containing docetaxel showed a significant ... ™ (abiraterone acetate) plus prednisone compared to ...
Cached Medicine Technology:Northwest Biotherapeutics Further Expands Ongoing Brain Cancer Trial 2Northwest Biotherapeutics Further Expands Ongoing Brain Cancer Trial 3Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 2Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 3Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 4Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 5Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 6
(Date:9/3/2015)... ... September 03, 2015 , ... B. E. Smith, the only ... lead a national chief executive officer recruitment for Melissa Memorial Hospital ... industry, B. E. Smith has recently placed more than 1,000 healthcare executives into ...
(Date:9/3/2015)... ... ... Global Vision , the world leader in the development of innovative ... inspection solutions, ScanProof and ArtProof at Packaging Innovations 2015. , Join ... , Be the first to get a sneak peek of Intelligent Proofreading. Global Vision’s ...
(Date:9/3/2015)... ... September 03, 2015 , ... DiabetesSisters ... pleased to announce the additional of Carol Wysham, MD, to their esteemed Board ... Diana Karczmarczyk, Donna Rice, David Warren, Matt Stella, Tricia Cedotal, Andrea Thomas, Wanda ...
(Date:9/3/2015)... ... ... ProScrub is a set of automated tools that allow Final Cut Pro ... without the use of keyframes. Utilize ProScrub's powerful sliders to determine the number ... to energetic video productions. ProScrub is a Final Cut Pro X ...
(Date:9/3/2015)... ... 03, 2015 , ... AvePoint, the established leader in enabling enterprise ... 4 – AvePoint’s solution for facilitating two-way collaboration and external sharing without ever ... This is the fifth consecutive year an AvePoint product has made the list. ...
Breaking Medicine News(10 mins):Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 3Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:Carol H. Wysham, MD, Joins DiabetesSisters Board of Directors 2Health News:FCPX Effects Developer Releases ProScrub for Final Cut Pro X 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 3Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 4
... the disheartening reasons behind her recent weight loss. ... emaciated in all her recent public appearances, admitted that she ... revealed that her worrying weight loss is a result of ... lean and this year I lost my mom and I've ...
... Moylan of St.Lucie County was driven to a West ... for urgent treatment of a splitting headache. ... behind his right ear. And his wife April Moylan ... wife offered conflicting explanations throughout the day, the latter ...
... of the first studies of social sources of alcohol ... were willing to purchase alcohol for underage youth .Many ... Most of them obtain alcohol from social sources of ... opposed to commercial sources. , ,Many types ...
... to worry about the doctor's needle, for a new study ... just as well as injections. ,The first of ... showed that kids children given oral treatment recovered as quickly, ... were able to go home sooner than those given intravenous ...
... of CD38 gene prevented mice on high-fat diets from gaining weight. ... researchers led by Eduardo Chini at Mayo Clinic. ,As ... one with the gene CD38 and the other without. Each group ... fat. In a second test, each group was fed a standard ...
... Tuesday with the death of a ninth child who contracted ... centre said. ,The death came as a ... officials accused in the case for negligence, corruption and fraud. ... in prison. ,The accused have all denied the ...
Cached Medicine News:Health News:Headache Complaint Leads to Removal of Bullet 2Health News:Underage Youth Get Alcohol from Social Sources 2Health News:Underage Youth Get Alcohol from Social Sources 3Health News:Oral Treatment as Effective as Injections in Treating Kids With Pneumonia 2Health News:Boffins Identify Gene That Helps Regulates Body Weight 2
... The Stryker Threaded ... surgeon yet another choice ... tunnel. Dilators provide compaction ... The compaction of bone ...
... Stryker Conquest Suture Retrievers ... that pierce through soft ... through the tissue to ... Conquest Retrievers are front ...
... The Arthroscopy Scissor is ideal for excising ... tissue debris in the joint. The serrated edge ... as well as hold tissue within the jaws ... left and right jaw curvatures, are the perfect ...
... offers state-of-the-art quality in an instrument of ... durability. Low profile cutting tips allow access ... I instruments are available in just about ... required for large and small joint arthroscopic ...
Medicine Products: